Rosemarie D L C Bernabe - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

BMC Medical Ethics|April 24, 2012

The risk-benefit task of research ethics committees: an evaluation of current approaches and the need to incorporate decision studies methodsRosemarie D L C Bernabe, Ghislaine J M W van Thiel, Jan A M Raaijmakers, et al.

BMC Medical Ethics|October 28, 2020

Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?Rosemarie D L C Bernabe, Ghislaine J M W van Thiel, Nancy S Breekveldt, et al.

BMC Medical Research Methodology|June 1, 2013

Phase IV non-inferiority trials and additional claims of benefitRosemarie D L C Bernabe, Grace Wangge, Mirjam J Knol, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

BMC Medical Ethics|April 24, 2012

The risk-benefit task of research ethics committees: an evaluation of current approaches and the need to incorporate decision studies methodsRosemarie D L C Bernabe, Ghislaine J M W van Thiel, Jan A M Raaijmakers, et al.

BMC Medical Ethics|October 28, 2020

Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?Rosemarie D L C Bernabe, Ghislaine J M W van Thiel, Nancy S Breekveldt, et al.

BMC Medical Research Methodology|June 1, 2013

Phase IV non-inferiority trials and additional claims of benefitRosemarie D L C Bernabe, Grace Wangge, Mirjam J Knol, et al.

Pageof 2